148 related articles for article (PubMed ID: 2572323)
1. Bopindolol and atenolol in patients with stable angina pectoris. Double-blind randomized comparative trial.
Hertzeanu H; Shemesh J; Loidl AF; Kellermann JJ
Cardiology; 1989; 76(4):312-8. PubMed ID: 2572323
[TBL] [Abstract][Full Text] [Related]
2. Comparison of bopindolol and atenolol in chronic stable angina pectoris.
Fitscha P; Meisner W; Tiso B
Eur J Clin Pharmacol; 1990; 38(1):81-4. PubMed ID: 1970300
[TBL] [Abstract][Full Text] [Related]
3. Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension.
Colnago R; Meregalli M; Turri D; Nazzari M; Fiorella G; Guffanti EE; Mazzola C
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):347-52. PubMed ID: 2887520
[TBL] [Abstract][Full Text] [Related]
4. Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris.
Antalóczy Z; Kekes E
Zhongguo Yao Li Xue Bao; 1989 May; 10(3):222-6. PubMed ID: 2609991
[TBL] [Abstract][Full Text] [Related]
5. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
Rousseau MF; Pouleur H; Cocco G; Wolff AA
Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
[TBL] [Abstract][Full Text] [Related]
7. Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension.
Schiess W; Welzel D; Gugler R
Eur J Clin Pharmacol; 1984; 27(5):529-34. PubMed ID: 6151506
[TBL] [Abstract][Full Text] [Related]
8. Effects of bevantolol and atenolol on symptoms, exercise tolerance and metabolic risk factors in angina pectoris.
Salonen JT; Taskinen E; Salonen R; Seppänen K; Venäläinen J; Rauramaa R
Am J Cardiol; 1986 Nov; 58(12):35E-40E. PubMed ID: 2878600
[TBL] [Abstract][Full Text] [Related]
9. Bopindolol in chronic stable angina pectoris: duration and extent of antianginal action.
Carboni GP; Scardovi AB; D'Ermo M; Prati PL
Br J Clin Pharmacol; 1991 Dec; 32(6):755-7. PubMed ID: 1685090
[TBL] [Abstract][Full Text] [Related]
10. Atenolol and celiprolol for stable angina pectoris.
McLenachan JM; Findlay IN; Henderson E; Wilson JT; Dargie HJ
Am J Cardiol; 1988 Feb; 61(5):52C. PubMed ID: 2893533
[TBL] [Abstract][Full Text] [Related]
11. Bopindolol for the treatment of chronic stable angina pectoris--a clinical study of the relationship between dose and effect.
Holmes D; Fryda-Kaurimsky Z; Krueger K
Cardiology; 1990; 77(6):459-65. PubMed ID: 1981493
[TBL] [Abstract][Full Text] [Related]
12. Value of the addition of amlodipine to atenolol in patients with angina pectoris despite adequate beta blockade.
Dunselman PH; van Kempen LH; Bouwens LH; Holwerda KJ; Herweijer AH; Bernink PJ
Am J Cardiol; 1998 Jan; 81(2):128-32. PubMed ID: 9591892
[TBL] [Abstract][Full Text] [Related]
13. Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol.
Quyyumi AA; Wright C; Mockus L; Fox KM
Br Med J (Clin Res Ed); 1984 Oct; 289(6450):951-3. PubMed ID: 6148991
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of carvedilol and atenolol efficacy in patients with stable effort angina].
Martsevich SIu; Koniakhina IP; Alimova EV; Kutishenko NP; Lerman OV
Ter Arkh; 2001; 73(1):38-41. PubMed ID: 11234138
[TBL] [Abstract][Full Text] [Related]
16. Nifedipine gastrointestinal therapeutic system versus atenolol in stable angina pectoris. The Netherlands Working Group on Cardiovascular Research (WCN).
de Vries RJ; van den Heuvel AF; Lok DJ; Claessens RJ; Bernink PJ; Pasteuning WH; Kingma JH; Dunselman PH
Int J Cardiol; 1996 Dec; 57(2):143-50. PubMed ID: 9013266
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up.
Kohli RS; Khurmi NS; Kardash MM; Hughes LO; Lahiri A; Raftery EB
Eur Heart J; 1985 Oct; 6(10):845-50. PubMed ID: 2866960
[TBL] [Abstract][Full Text] [Related]
18. Importance of ancillary properties of beta blockers in angina: a study of celiprolol and atenolol.
McLenachan JM; Wilson JT; Dargie HJ
Br Heart J; 1988 Jun; 59(6):685-9. PubMed ID: 2899439
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, randomized, placebo-controlled study of molsidomine in patients with stable effort angina receiving beta-blocker therapy with atenolol.
De Backer GG; Derese A
Am Heart J; 1985 Mar; 109(3 Pt 2):678-81. PubMed ID: 3883735
[TBL] [Abstract][Full Text] [Related]
20. Comparison of bevantolol and atenolol in chronic stable angina.
Rodrigues EA; Lawrence JD; Dasgupta P; Hains AD; Lahiri A; Wilkinson PR; Raftery EB
Am J Cardiol; 1988 Jun; 61(15):1204-9. PubMed ID: 2897780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
